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Objective: Abdominal aortic aneurysm (AAA) rupture is associated with a systemic inflammatory response syndrome,
characterized by increased microvascular permeability and neutrophil sequestration, leading to multiorgan dysfunction.
We examined the role of a novel complement factor 5a (C5aR) receptor antagonist, the cyclic peptide AcF-(OpdChaWR),
in attenuation of pathologic complement activation and tissue injury in a model of AAA rupture.
Methods: Anesthetized rats were randomized to sham (control) or shock and clamp (sc) groups. Animals in the sc group
underwent 1 hour of hemorrhagic shock (mean arterial blood pressure <50 mm Hg), followed by 45 minutes of
supramesenteric aortic clamping, then 2 hours of resuscitated reperfusion. Animals in the sc group were randomized to
receive an intravenous bolus of C5aR antagonist at 1 mg/kg or saline solution control at the end of hemorrhagic shock.
Intestinal and pulmonary permeability to iodine 125–labeled albumin was measured as an indicator of microvascular
permeability. Tissue myeloperoxidase activity, proinflammatory cytokine tissue necrosis factor- (TNF-) protein and
mRNA, and C5aR mRNA levels were measured as indicators of neutrophil sequestration and inflammatory signaling,
respectively.
Results: Lung permeability index was significantly increased in the sc group compared with the sham group (4.43 
0.96 vs 1.30  0.17; P < .01), and prevented with treatment with C5aR antagonist (1.74  0.50; P < .03). Lung
myeloperoxidase activity was significantly increased in the the sc group compared with the sham group (2.41  0.34
U/mg vs 1.03 0.29 U/mg; P < .009), and significantly attenuated with treatment with C5aR antagonist (1.11 0.09
U/mg; P < .006). Lung TNF- protein levels were significantly elevated in both sc groups, whereas lung TNF-
mRNA expression was significantly downregulated in both sc groups compared with the sham group. Intestinal
permeability index was significantly increased in animals in the sc groups during reperfusion, compared with sham (P
< .001), which was attenuated in early reperfusion with treatment with C5a receptor antagonist. Data represent mean
SEM, group comparisons with analysis of variance and post hoc Scheffe´ test.
Conclusions: These results indicate that a potent antagonist of C5a receptor protects the rat intestine and lung from
neutrophil-associated injury in a model of AAA rupture. These data suggest that complement-mediated inflammation can
be modulated at the C5a receptor level, independent of proinflammatory TNF- production, and prevent acute local and
remote organ injury. (J Vasc Surg 2004;39:196-206.)
Abdominal aortic aneurysm (AAA) rupture continues
to confer a 40% to 75% in-hospital mortality rate, despite
improvements in surgical techniques and perioperative
care.1 The combined effects of hemorrhagic shock and
subsequent clamp-related lower torso ischemia are believed
to represent a “two hit” ischemic injury,2 which on reper-
fusion initiates a systemic inflammatory response syn-
drome, characterized by increased microvascular perme-
ability and neutrophil sequestration, leading to multiple
organ dysfunction syndrome.3 Multiple organ dysfunction
syndrome remains the primary cause of death in 70% of
patients who survive the initial surgery and a contributory
cause in the remainder.4,5 Reperfusion of the ischemic
lower torso after prolonged ischemia initiates a systemic
inflammatory response syndrome, characterized by proin-
flammatory cytokine3,6 and increased circulating polymor-
phonuclear (PMN) leukocyte activation.7 Pulmonary se-
questration of activated neutrophils is associated with
development of acute pulmonary microvascular injury8,9
and acute respiratory distress syndrome,10 and high subse-
quent mortality.
Complement system activation occurs in ruptured AAA
repair7 and in experimental models of ischemia-reperfusion
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injury to the lower limb11 and intestine.12 Activated prod-
ucts of the complement pathway, C3a and C5a, are potent
inflammatory mediators with myriad effects, including al-
teration of blood vessel permeability and tone,13 leukocyte
chemotaxis,14 and activation of multiple inflammatory cell
types.15 Support for the role of complement in inflamma-
tory tissue injury is evidenced by the attenuation of such
injury with anti-C5 antibody16 and C5a receptor (C5aR)
antagonist.17 However, the role of complement in inflam-
matory tissue injury after ruptured AAA remains largely
unknown.
The purpose of this study was to determine for the first
time the effects of a novel small molecule C5aR antagonist,
AcF-(OpdChaWR) (Phe[Orn-Pro-D-cyclohexylalanine-
Trp-Arg]), in a model of ruptured AAA. We hypothesized
that complement-mediated inflammation could be attenu-
ated at the C5a receptor level, reducing local intestinal and
remote acute lung injury.
MATERIAL AND METHODS
Animal care guidelines. All animals used in this study
were maintained in an accredited facility and cared for in
accordance with the recommendations of the Canadian
Council on Animal Care, the requirements of the Animals
for Research Act of the Province of Ontario, and the
regulations of the Animal Care Committee, The Toronto
Hospital, and the Guide for the Care and Use of Labora-
tory Animals [DHSS Publication No. (NIH)86-23, revised
1985].
Experimental design. Male Sprague-Dawley rats
(350-500 g) were used throughout the experiment. All
animals were anesthetized with pentobarbital sodium (50
mg/kg intraperitoneally). A tail vein and the right carotid
artery were cannulated with 22-gauge angiocatheters for
intravenous access and continuous monitoring of mean
arterial pressure (MAP), respectively.
Animals were randomized into two groups, sham (n 
6) and shock  clamp (sc; n  19). Animals in the sc
group were further randomized into C5aR antagonist–
treated (n  9) and control (n  10) groups. In the
treated group, small-molecule C5aR anatgonist, AcF-
(OpdChaWR) (Promics Pty Ltd, Queensland, Australia)
was administered intravenously over 2 minutes at the end
of hemorrhagic shock at a dose 2 mg/kg; the control
group received saline solution infusion. In all cases the
operator was blinded to the treatment given.
After a midline laparotomy, the abdominal aorta was
isolated at the superior mesenteric artery and just proximal
to the iliac bifurcation. Intestinal permeability was used as
an index of intestinal injury, and was measured as described.
In short, a 5-cm segment of jejunum was isolated and
perfused continuously with percutaneous inflow and out-
flow cannulas with 37°C Ringer lactate solution at a rate of
0.3 mL/min with an infusion pump (model AVI 480; 3M,
St Paul, Minn). For determination of intestinal and pulmo-
nary permeability, animals then received iodine 125–la-
beled albumin (1 Ci) via the tail vein catheter, and were
allowed to stabilize for 30 minutes to establish postopera-
tive equilibrium. Intestinal perfusate was collected every 10
minutes throughout the experiment, and samples of blood
(0.3 mL) were withdrawn at 1-hour intervals to measure
total albumin concentration and the specific activity of
125I-albumin for calculation of intestinal albumin loss.
In appropriate groups, shock was induced with blood
withdrawal from the carotid artery cannula into a plastic
heparinized syringe (500 U), which was maintained at
room temperature on a tube rocker, to reduce and maintain
MAP at 50 mm Hg for 1 hour. After 60 minutes of shock or
an equivalent control period, clamps were applied to the
abdominal aorta just proximal to the superior mesenteric
artery and at the iliac bifurcation. At this time, half of the
shed blood was infused into the tail vein. The clamps
remained in place for 45 minutes. Just before clamp re-
moval the remainder of the shed blood was reinfused.
Additional Ringer lactate solution was also administered, as
required, to resuscitate and maintain MAP at 100 mm Hg.
Reperfusion was continued for 120 minutes, at which time
the animals were killed with an overdose of pentobarbital
sodium. Tissue samples were excised, washed in ice-cold
saline solution, and rapidly frozen in liquid nitrogen and
stored at 70°C until analyzed for reverse transcriptase
polymerase chain reaction (RT-PCR), myeloperoxidase
(MPO), and cytokine levels.
Determination of pulmonary permeability. The left
lung was lavaged three times with 3.5 mL of Ringer lactate
solution, and the effluent bronchoalveolar lavage (BAL)
was collected. Blood and BAL fluid were weighed and
counted for 125I activity, and lung permeability index (LPI)
was calculated with the formula LPI BAL-125I(cpm/g)/
blood-125I (cpm/g).
Determination of intestinal permeability. To calcu-
late intraluminal intestinal albumin loss, all 10-minute ef-
fluent collections from the intestinal perfusion were
weighed, and a 1-mL sample of each was assayed for
125I-albumin activity with a gamma counter. Each blood
sample drawn during the experimental procedure was cen-
trifuged at 100,000 rpm, and 100 L of plasma was re-
moved for determination of albumin content and 125I-
albumin activity. The level of 125I in the blood samples was
regressed against time, and the slope of the curve was used
to determine the activity of this isotope in whole blood.
This was used to determine the specific activity of 125I per
microgram of total albumin to calculate intestinal albumin
loss in milligrams per gram dry weight of the perfused
intestinal segment.
Measurement of circulating complement activi-
ty. To assess complement activation, total serum hemo-
lytic activity was measured with the total hemolytic com-
plement (CH50) technique, as described.
11 Total
hemolytic complement activity (CH50) was determined in
serum with Compquik CH50 (Sigma, St Louis, Mo) with
antibody-coated sheep erythrocytes and compared with a
reference standard. Frozen serum samples (80°C) were
assayed as a single batch; intra-assay variability was less than
5%.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 1 Harkin et al 197
Determination of MPO activity. Tissues were as-
sayed for MPO, an index of neutrophil sequestration, as
described.18 In short, MPO activity was assessed at 37°C by
monitoring the change in absorbance at 655 nm over 3
minutes in a Cobas FARA II centrifugal analyzer (Roche
Diagnostic Systems, Montclair, NJ). The reaction mixture
contained 16 mmol/L of 3,3,5,5-tetramethylbenzidine
dissolved in N,N-dimethylformamide in 0.22 mol/L of
phosphate-buffered saline solution containing 0.11 mol/L
of sodium chloride (NaCl) at pH 5.4. The reaction was
initiated with addition of 3 mmol/L of hydrogen peroxide.
One unit of activity was defined as a one-unit change in
absorbance per minute at 37°C. Protein content of pulmo-
nary and intestinal samples was determined with the bicin-
choninic acid protein assay system (Pierce, Rockford, Ill).
MPO activity was expressed as units per milligram of
protein.
Measurement of TNF- in lung. One hundred mil-
ligrams of tissue was homogenized in 1 mL of phosphate-
buffered saline solution (0.4 mol/L of NaCl and 10
mmol/L of NaPO4) containing antiproteases (0.1
mmol/L of phenylmethyl sulfonyl fluoride, 0.1 mmol/L of
benzethonium chloride, 10 mmol/L of ethylenediami-
netetraacetic acid, and 20 KI [potassium chloride] of apro-
tinin A) and 0.05% Tween 20. The samples were then
centrifuged for 10 minutes at 3000g, and the supernatant
was immediately used for commercial enzyme-linked im-
munosorbent assay at a 1:2 dilution in assay dilution buffer,
according to the manufacturer’s instructions (R&D Sys-
tems, Minneapolis, Minn). Protein contents of samples
were determined with the bicinchoninic acid protein assay
system (Pierce). Cytokine concentrations were expressed as
picograms per milligram of protein.
RNA isolation and semiquantitative RT-
PCR. Lung tissue from rats was obtained at the end of the
experiment and prepared as described above. Total RNA
was isolated with the TRTzol method (Life Technologies,
Rockville, Md) according to the manufacturer’s instruc-
tions. Digestion of any contaminating DNA was achieved
with treatment of samples with RQ1 Rnase-free Dnase
(Promega, Madison, Wis).
Semiquantitative RT-PCR was performed with 1 g of
RNA with Superscript II RNase H Reverse Transcriptase
(Life Technologies, Grand Island, NY) according to the
manufacturer’s instructions and as described.19 The prim-
ers for the “housekeeping” gene GAPDH were 5 primer
5-GCC TCG TCT CAT AGA CAA GAT G-3 and 3
primer 5-CAG TAG ACT CCA CGA CAT AC-3 . PCR
was performed with primers for C5aR—5 primer 5-TAT
AGT CCT GCC CTC GCT CAT-3 and 3 primer 5-TCA
CCA CTT TGA GCG TCT TGG-3—and TNF-—5
primer 5-GGC AGG TCT ACT TTG GAG TCA TTG
C-3 and 3 primer 5 ACA TTC GAG GCT CCA GTG
AAT TCG G-3. For each primer couple the following
PCR conditions were used: C5aR, after a “hot start” for 5
minutes at 94°C, 30 cycles were used for amplification,
with a melting temperature of 94°C and an annealing
temperature of 60°C, and an extending temperature of
72°C, each for 1 minute, followed by a final extension at
72°C for 8 minutes; TNF-, after a “hot start” for 3
minutes at 94°C, 32 cycles were used for amplification,
with a melting temperature of 94°C and an annealing
temperature of 60°C, and an extending temperature of
72°C, each for 1 minute, followed by a final extension at
72°C for 10 minutes. The RT-PCR product was confirmed
with electrophoresis of samples in a 1.2% agarose gel.
Experiments were conducted in which total RNA from
sample was amplified with different cycle numbers for
GAPDH and C5aR primers to ensure that RNA bands after
30 cycles were detected within the linear part of the ampli-
fying curves. To rule out contaminating DNA as responsi-
ble for results, controls for the samples were performed in
which RT-PCR was performed similarly, except for absence
of reverse transcriptase. These controls showed no detect-
able bands for C5aR mRNA or TNF-, respectively (data
not shown). The amount of amplified product was esti-
Fig 1. Lung permeability index to iodine 125–labeled albumin
was significantly increased in the shock and clamp group (sc)
compared with the sham group (*P  .01), and was significantly
prevented with treatment with C5a receptor antagonist (C5aRA;
#P  .03). MPO, Myeloperoxidase.
Fig 2. Lung tissue myeloperoxidase (MPO) activity was signifi-
cantly increased in the shock and clamp group (sc) compared
with the sham group (*P .009), and was significantly attenuated
with treatment with C5a receptor antagonist (C5aRA; #P 
.006).
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mated with densitometry of ethidium bromide–stained
1.2% agarose gels with a CCD camera and Imagemaster
VDS software (Pharmacia, Uppsala, Sweden). Results are
presented semiquantitatively, referring to equal loading of
the relative amount of transcribed mRNA.
Statistical analysis. Summary values are presented as
mean 	 SEM, and differences between group mean were
considered significant at P  .05. End point data were
analyzed with one-way ANOVA, and with the post hoc
Scheffe´ test for individual between-group comparison if
significance was determined with ANOVA. Repeated mea-
sures, such as blood pressure and intestinal permeability
index (IPI), were analyzed with repeated measures two-way
ANOVA, with group and time as independent variables.
RESULTS
Pulmonary permeability. LPI to 125I-labeled albu-
min was significantly increased in the sc group compared
with the sham group (4.43 	 0.96 vs 1.30 	 0.17; P 
.01), and was significantly prevented with treatment with
C5a receptor antagonist (1.74 	 0.50; P  .03; Fig 1).
Pulmonary MPO activity. Lung tissue MPO activity
was significantly increased in the sc group compared with
the sham group (2.41 	 0.34 U/mg vs 1.03 	 0.29
U/mg; P  .009), and significantly attenuated with treat-
ment with C5a receptor antagonist (1.11	 0.09 U/mg; P
 .006; Fig 2).
Pulmonary TNF- concentration. Lung TNF- lev-
els were significantly elevated in the sc group compared
with the sham group (89.70 	 13.83 pg/mg protein vs
47.57 	 11.22 pg/mg protein; P  .03), but was not
prevented with treatment with C5a receptor antagonist
(78.71 	 15.78 pg/mg protein; P  NS; Fig 3).
Intestinal permeability. The rate of intraluminal in-
testinal albumin loss, IPI, remained stable throughout the
entire experimental period in sham animals. In sc animals
IPI remained stable during stabilization, hemorrhage, and
clamp periods; however, at reperfusion there was a statisti-
cally significant increase in IPI (Fig 4). After 30 minutes of
reperfusion IPI was significantly increased in sc animals,
compared with pre-shock levels (8.05 
 102 	 3.59 

102 vs 0.72 
 102 	 0.51 
 102; P  .0001) and
control levels (8.05
 102	 3.59
 102 vs 1.75
 102
	 0.33
 102; P .0001), and remained at similar levels
throughout the 120-minute reperfusion. Treatment with
C5a receptor antagonist significantly reduced the increased
IPI in early reperfusion; after 30 minutes of reperfusion IPI
was significantly reduced in C5aR antagonist-treated ani-
mals compared with untreated sc animals (2.82 
 102
	 0.91
 102 vs 8.05
 102 	 3.59
 102; P .01).
However, as reperfusion progressed IPI increased, even in
the treated group, to mirror untreated sc levels (Fig 4).
Intestinal MPO activity. Intestinal tissue MPO activ-
ity was not significantly increased in the sc group com-
pared with the sham group (3.93	 0.66 U/mg vs 3.34	
0.53 U/mg; P  NS). Of interest, intestinal MPO activity
was significantly reduced in C5a receptor antagonist–
treated animals compared with untreated sc animals
(1.86 	 0.26 U/mg vs 3.93 	 0.66 U/mg; P  .01) and
sham animals (3.34 	 0.53 U/mg; P  .017; Fig 5).
Intestinal TNF- concentration. Intestinal TNF-
levels were significantly elevated in sc animals compared
with sham animals (73.02 	 10.12 pg/mg protein vs
45.42 	 6.23 pg/mg protein; P  .038), but not pre-
vented with treatment with C5a receptor antagonist (72.00
	 13.95 pg/mg protein; P  NS; Fig 6).
Blood pressure and resuscitation requirements.
MAP remained stable throughout the entire experimental
period in sham animals (Fig 7, A), requiring minimal
intravenous fluid resuscitation with Ringer lactate solution
Fig 3. Lung tissue necrosis factor- (TNF-) levels were significantly elevated in the shock and clamp group (sc)
compared with the sham group (*P  .03), but were not prevented with treatment with C5a receptor antagonist
(C5aRA; P  NS).
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(Fig 7, B). In sc animals MAP was reduced during hem-
orrhagic shock to 50 mm Hg or less for 1 hour, as defined
by the protocol; with application of a supramesenteric
aortic clamp, MAP increased significantly compared with
pre-shock levels (158	 9.0 mm Hg vs 117	 3.0 mm Hg;
P .001). In sc animals after removal of the aortic clamp
MAP decreased progressively during reperfusion to a nadir
after 120 minutes of reperfusion (68 	 6.0 vs pre-shock
117 	 3.0; P  .001), despite vigorous fluid resuscitation
with intravenous infusion of Ringer lactate solution (69.3
	 8.5 mL). Animals treated with C5a receptor antagonist
maintained significantly better MAP during reperfusion
compared with untreated sc animals (95	 5.3 mm Hg vs
68 	 6.0 mm Hg; P  .01; Fig 7, A), and required less
intravenous fluid resuscitation (60.0 	 7.0 mL vs 69.3 	
8.5 mL; P  .1, NS; Fig 7, B).
Complement activation (CH50) in model of rup-
tured AAA. Compared with control animals, CH50 levels
dropped significantly in our model of ruptured AAA (sc),
and this was not altered with treatment with C5aR antag-
onist (Fig 8).
Expression of C5aR and TNF- in lung tissue. Ex-
pression of C5aR mRNA in lung tissue was significantly
reduced in our model of ruptured AAA (sc) compared
with sham animals (0.44	 0.04 vs 2.03	 0.63; P .012).
This was only partially prevented with treatment with C5aR
antagonist (Fig 9, A, B).
Expression of TNF- mRNA in lung tissue was signif-
icantly reduced in our model of ruptured AAA (sc) com-
pared with sham animals (0.57	 0.22 vs 0.08	 0.04; P
.019). This was unaltered with treatment with C5aR antag-
onist (Fig 10, A, B).
DISCUSSION
Ruptured AAA initiates a systemic inflammatory re-
sponse syndrome, characterized by increased microvascular
permeability and activated neutrophil sequestration,3 lead-
ing to multiple organ dysfunction syndrome,6 which is a
major factor in most of the 35% to 70% in-hospital mortality
rate reported by most specialist units.1 The development of
a variety of novel anti-complement compounds has re-
newed interest in complement as a therapeutic target in the
critically ill. In this ruptured AAA model, hemorrhagic
shock for 1 hour at MAP 50 mm Hg, followed by 45
minutes of supramesenteric aortic clamping and 120 min-
utes of reperfusion, resulted in significant intestinal and
pulmonary injury, and refractive shock, despite vigorous
fluid resuscitation. Significant reduction in total serum
hemolytic activity (CH50) suggests a major role for com-
plement activation in the early inflammatory response in
this model of ruptured AAA. The CH50 assay measures
both the classic activation and the terminal complement
components, and is frequently used in rat models as an
indicator of total complement activity in blood.20 Comple-
ment activation occurs in the early stages of inflammation,
releasing activated complement components C3a, C4a,
C5a, potent anaphylatoxins that alter vascular tone and
permeability. They also chemotactically recruit and activate
Fig 4. Rate of intraluminal intestinal albumin loss, intestinal permeability index (IPI), remained stable throughout the
entire experimental period in sham animals. In shock and clamp animals (sc), IPI remained stable during stabilization,
hemorrhage, and clamp periods. During reperfusion IPI was significantly increased in sc animals, compared with
pre-shock levels (*P  .0001) and with control levels (*P  .0001), and remained at similar levels throughout the
120-minute reperfusion. Treatment with C5a receptor antagonist (C5aRA) significantly reduced the increased IPI in
the first 60 minutes of (early) reperfusion, compared with untreated sc animals (#P  .01). However, as reperfusion
progressed IPI increased, even in the treated group, to mirror untreated sc levels. s, Shock; c, clamping; r, reperfusion.
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inflammatory cells, in particular C5a, and lead to release of
cytokines, such as TNF-. Subsequent formation of the
membrane attack complex C5b-C9 is directly lytic to cells.
In this study we have demonstrated for the first time that
the local and systemic injury associated with ruptured AAA
can be attenuated with a novel complement component
C5a receptor antagonist, the cyclic peptide AcF-
(OpdChaWR), in a rat model.
The additive effects of hemorrhagic shock and lower
torso ischemia-reperfusion injury comprise the major etio-
pathologic basis of organ injury in ruptured AAA.2 Our
previously reported rat model of ruptured AAA reproduces
the sequential and synergistic harmful effects of hemor-
rhagic shock followed by aortic clamp–induced lower torso
ischemia-reperfusion injury.18 Although infrarenal aortic
clamping may often be sufficient to gain control of rup-
tured AAA, suprarenal or even supraceliac clamping is not
uncommon, and is essential in unstable patients and those
with juxtarenal aneurysms. In our model a direct clamp-
related ischemic injury involved the renal and intestinal
circulation, and although this is not the most common
clinical scenario, it is associated with a severe inflammatory
Fig 5. Intestinal tissue myeloperoxidase (MPO) activity was not significantly increased in the shock and clamp group
(sc) compared with the sham group (PNS). Of interest, intestinal MPO activity was significantly reduced in animals
treated with C5a receptor antagonist (C5aRA) compared with untreated sc animals (*P .01) and the sham group
(#P  .017).
Fig 6. Intestinal tissue necrosis factor- (TNF-) levels were significantly elevated in the shock and clamp group (sc)
compared with the sham group (*P  .038), but were not prevented with treatment with C5a receptor antagonist
(C5aRA; P  NS).
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 1 Harkin et al 201
Fig 7. Mean arterial blood pressure (MAP) remained stable throughout the entire experimental period in sham animals
(A), requiring minimal intravenous fluid resuscitation with Ringer lactate solution (B). In shock and clamp animals
(sc), MAP was reduced during hemorrhagic shock to 50 mm Hg or less for 1 hour, as defined by the protocol. On
application of the supramesenteric aortic clamp, MAP increased significantly compared with pre-shock levels (P 
.001). In sc animals after removal of the aortic clamp, MAP decreased progressively during reperfusion to a nadir after
120 minutes of reperfusion (#P .001), despite vigorous fluid resuscitation with intravenous infusion of Ringer lactate
solution (69.3 	 8.5 mL). Animals treated with C5a receptor antagonist (C5aRA) maintained significantly better
MAP during reperfusion compared with untreated sc animals (#P  .01; A), and required less intravenous fluid
resuscitation (P  .1, NS; B). s, Shock; c, clamping; r, reperfusion.
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response, making our successful modulation of injury with
C5aR antagonism even more impressive. Intestinal injury
in this model was associated with a significant increase in
intestinal capillary permeability to 125I-albumin immedi-
ately after release of the supramesenteric aortic clamp, an
increase that persisted throughout the reperfusion period.
Treatment with the C5aR antagonist significantly pre-
vented increased intestinal permeability in early reperfu-
sion; however, in late reperfusion intestinal permeability
increased to that in nontreated sc animals. Increased
intestinal permeability has been reported after ruptured
AAA and elective abdominal21 and thoracoabdominal22
aneurysm repair in human beings, and is associated with
increased morbidity and mortality. Injury to the intestine is
twofold in that the initial global hypoxia during hemor-
rhagic shock is compounded by the direct ischemia-reper-
fusion injury during and after release of the supramesenteric
aortic clamp. Intestinal ischemia-reperfusion injury is asso-
ciated with neutrophil sequestration and increased micro-
vascular permeability, and can be modulated with neutro-
phil depletion or antibodies directed against neutrophil
adhesion molecules.23 Activated complement components
alter vascular tone and permeability, chemotactically attract
and activate neutrophils, and are integral to intestinal reper-
fusion injury.12 By inhibiting early interaction between the
activated complement component C5a and its target cells
on the intestinal vascular endothelium, and circulating
immune cells, we have reduced the severity of the initial gut
injury in this model. Furthermore, limb ischemia-reperfu-
sion injury, when associated with systemic inflammation,
induces intestinal injury associated with translocation of
bacterial fragments across a damaged intestinal capillary
barrier,24 with the resultant endotoxemia25 producing an
exaggerated inflammatory response. This has led many to
suggest that the gut drives the inflammatory response to a
variety of critical illnesses.26,27 Complement is important in
neutrophil activation in response to endotoxin28; therefore
complement receptor blockade could decrease the proin-
flammatory effects of endotoxin in early reperfusion. How-
ever, as reperfusion continues intestinal injury increases,
most likely as a result of the cellular effects of ischemia-
reperfusion injury and parallel activation of cytokine and
proinflammatory mediator cascades. Our findings are in
agreement with those of previous studies, which show that
direct intestinal ischemia-reperfusion injury can be attenu-
ated by blocking the complement cascade at various
points.17,29 The reduction in intestinal MPO concentra-
tion compared in both untreated sc groups is interesting,
and may suggest that local complement-induced neutro-
phil chemotaxis and activation are crucial to neutrophil
sequestration and intestinal injury in this model. Comple-
ment activation in vitro stimulates rapid adhesion of neu-
trophils to endothelial target cells.30 In this study sc
animals had significantly increased intestinal levels of proin-
flammatory cytokine TNF- compared with sham animals,
Fig 8. Total serum hemolytic activity (CH50) measured at the end
of the experimental period is expressed as a percentage of reference
serum value. Significant reduction in serum hemolytic activity is
noted in the shock and clamp group (sc), and this was not
significantly attenuated with treatment with C5a receptor antago-
nist (C5aRA; P  .004, analysis of variance).
Fig 9. A, Expression of C5a receptor antagonist (C5aRA) in lung
tissue is downregulated from control levels by shock and clamp
injury (sc), and this is only partially attenuated in the C5aRA-
treated group. B, Densitometry analysis demonstrates significant
downregulation of C5aRA in the sc group, which is prevented in
the C5aRA-treated group (P  .012, analysis of variance).
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and this was not altered with treatment with C5aR antag-
onist. Although activated complement causes release of
TNF- from a variety of cell types, including immune cells,
by a receptor-mediated effect, a variety of other mediators
created after ischemia-reperfusion injury, such as arachi-
donic acid metabolites, also stimulate cytokine release.
Ruptured AAA is associated with noncardiac acute
interstitial pulmonary edema and associated hypoxemia,
analogous to acute respiratory distress syndrome, which has
a grave prognosis. In this model of ruptured AAA the sc
group had significantly increased pulmonary permeability
to 125I-albumin and lung MPO levels. Treatment with
C5aR antagonist significantly prevented increased pulmo-
nary permeability and neutrophil sequestration. The mech-
anism whereby lung injury in this model is primarily due to
neutrophil adherence, sequestration, and subsequent respi-
ratory burst-induced oxidative injury is supported by the
observation that lung injury can be attenuated with anti-
CD18 monoclonal antibodies.18 In this model, antago-
nism of the C5a receptor on target cells reduces neutrophil
sequestration and subsequent microvascular hyperperme-
ability. In this model the combination of the systemic
hemorrhagic shock injury, compounded by lower torso
ischemia-reperfusion, produces a severe acute lung injury.
Abrogation of C5a-induced neutrophil chemotaxis and
activation in the pulmonary circulation may in part explain
the attenuation of injury in this study. Significant down-
regulation of C5aR mRNA expression in the lung is noted
after sc injury in this model, which is attenuated in the
C5aR antagonist–treated group. C5aR activation is associ-
ated with downregulation of C5aR expression, and we have
shown this. However, it is not possible to define the exact
mechanism by which this downregulation occurs from
these data. C5aR activation has been reported to cause
upregulation of 2-integrin on neutrophils
30 and endothe-
lial P-selectin and intercellular adhesion molecule–1,31 and
thus would promote neutrophil adherence and transmigra-
tion into the lung parenchyma, where it would induce
oxidative injury. Therefore prevention of C5aR activation
may explain the diminution of lung injury in our model.
C5a receptor blockade does not affect formation of the
cytolytic membrane attack complex C5b-C9, which has
been implicated in acute lung injury32; however, its effects
may be more important in the lower torso and intestine,
where direct ischemic injury occurred, than in the remotely
injured lung. In this acute model modulation of this early
complement-dependent injury may be sufficient to convert
lethal acute lung failure to recoverable acute lung dysfunc-
tion. As with the intestinal injury, TNF- levels in the lung
significantly increase after sc, and this is not affected with
treatment with C5aR antagonist. TNF- is produced after
a variety of stresses, and induces direct lung injury.33 Con-
versely, expression of TNF- mRNA is reduced signifi-
cantly in both injured groups of animals. Taken together,
inasmuch as both C5aR and TNF- mRNA expression are
reduced, there may be a common signal involved. Alterna-
tively, reduced expression at this early stage of reperfusion
may reflect the severity of hypoxic cellular injury in this
model. The phenomenon of “cell stunning” suggests that
an injured cell may have reduced nonessential metabolic
processes, and therefore nonessential transcription or trans-
lation processes are reduced.34
Throughout the experimental procedure sham animals
maintained stable blood pressure with minimal require-
ment for fluid resuscitation. Animals in the sc group
required significant fluid resuscitation from the start of the
reperfusion period, after aortic clamp release, to maintain
MAP. After initial response to fluid resuscitation in the first
hour of reperfusion, shock refractory to fluid resuscitation
developed in the second hour of reperfusion, requiring
large volumes of intravenous fluid to maintain blood pres-
sure. Treatment with C5aR antagonist significantly pre-
vented the severe hypotension observed in the untreated
group, and required less fluid resuscitation. Aortic clamp
Fig 10. A, Expression of tissue necrosis factor- (TNF-) in lung
tissue is downregulated from control levels by shock and clamp
injury (sc), and this is only partially attenuated in the group
treated with C5a receptor antagonist (C5aRA). B, Densitometry
analysis demonstrates significant downregulation of TNF- in the
sc group, which is not altered with treatment with C5aRA (P 
.019, analysis of variance).
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release is associated with a variety of vasoactive effects,
including hypovolemia from peripheral vasodilation and
increased vascular permeability, reperfusion of ischemic
tissues with circulation of vasoactive mediators and metab-
olites, and myocardial depressant factors.35 Hemorrhagic
shock itself initiates a cascade of proinflammatory mediator
induction,36 and oxidative injury is associated with the
degree of complement activation.37 Reducing microvascu-
lar permeability and immune cell activation via complement
receptor–specific pathways reduces the degree and duration
of hypotension in this model. This is probably a reflection
of the reduced third space fluid loss from prevention of
complement and complement-dependent increases in mi-
crovascular permeability. Complement activation also af-
fects vascular tone and histamine release, prevention of
which may also help maintain vascular resistance.38 Re-
duced organ injury, and perhaps reduced myocardial de-
pression, may also allow the animal to better handle the
fluid load required to maintain target blood pressure.
In conclusion, we have shown for the first time that a
novel C5a receptor antagonist can reduce local intestinal
and remote lung injury in a model of ruptured AAA. This
treatment appears to mediate its effects by reducing the
inflammatory stimulus to tissue neutrophil sequestration,
by reducing activated complement–immune cell interac-
tion. Antagonism of the human C5a receptor may repre-
sent a realistic therapeutic target in a group of patients with
ruptured AAA, which currently is associated with high
mortality.
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